Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP)
(WorldNews Indonesia)

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP) 22 Sep 2020 18:00 CEST Company Name QUANTUM GENOMICS ISN FR0011648971 Market Euronext Growth Symbol ALQGC Quantum Genomics to receive up to $19 million in upfront and milestone payments plus double-digit royalties on sales OEP to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in South-East Asia, Australia and New Zealand Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult to...